Leipzig Heart Science

Leipzig Heart Science gGmbH (LHS) is a German non-profit research organization dedicated to advancing cardiovascular medicine through clinical science and innovation. Based in Leipzig, the company serves as a sponsor and coordinator for significant multicenter clinical trials, including the COMPLETE-NSTEMI and DOUBLE-CHOICE studies. LHS collaborates closely with the Heart Center Leipzig and the Leipzig Heart Institute to evaluate new medical devices, surgical procedures, and digital health solutions such as AI-enhanced diagnostics. Its mission is to accelerate the translation of research findings into standard clinical practice to improve outcomes for patients with heart disease. The organization is primarily funded through public grants and partnerships, maintaining a strong focus on transparency and the public dissemination of scientific results.